Roche is not the end all be all for testing by a long shot. Penny traders brought it up and penny traders brought it down. Thought about selling at .12 as in the black but curious as to where this goes. I have a relatively small investment. Looks like just about all of my conferences and all hands meetings are canceled or postponed, including one with a few Roche VP's. Roche has virtually either outsourced or moved its entire clinical trial teams and RBM to India. There will be better testing devices to market, this was just an opening chess move by an administration whose CDC did not take this seriously enough.